List of works - Chris D Skedgel

Adherence to guidelines and the screening tool of older persons' potentially inappropriate prescriptions criteria for colchicine dosing for gout treatment in beneficiaries of the Nova Scotia Seniors' Pharmacare Program

scientific article published on 18 September 2015

Adjuvant chemotherapy for breast cancer: a cost-utility analysis of FEC-D vs. FEC 100.

scientific article published on 5 October 2007

Adjuvant trastuzumab for breast cancer: uncertainties in clinical and economic evidence following early stopping of the HERA trial

scientific article published in May 2011

An incremental cost analysis of telehealth in Nova Scotia from a societal perspective

scientific article published on 01 January 2005

An incremental economic evaluation of targeted and universal influenza vaccination in pregnant women.

scientific article published in November 2011

Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital

scientific article published on 18 August 2013

Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial

scientific article

Considerations and costs of disclosing study findings to research participants

scientific article published on April 2004

Constant-sum paired comparisons for eliciting stated preferences: a tutorial

scientific article

Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review.

scientific article published on 30 August 2016

Cost-effectiveness of interferon beta-1b in slowing multiple sclerosis disability progression. First estimates

scientific article published in January 2000

Cost-utility analysis of proton pump inhibitors and other gastro-protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti-inflammatory agents

scientific article published on 20 March 2010

Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole

scientific article published on 02 August 2006

Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole.

scientific article published on 4 January 2007

Cost-utility of adjuvant zoledronic acid in patients with breast cancer and low estrogen levels

scientific article

Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer.

scientific article

Drug attributes associated with the selection of drugs for reimbursement: a pilot stated preferences experiment with Canadian stakeholders

scientific article published on 13 September 2018

Effect of copayments on drug use in the presence of annual payment limits.

scientific article published on June 2007

Gout in the elderly--a population health study

scientific article published on 13 March 2009

Hospital-based psychiatric service utilization and morbidity in multiple sclerosis

scientific article published in August 1998

How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?

scientific article published on 15 August 2007

Identification of patients with systemic lupus erythematosus in administrative healthcare databases

scientific article published on 23 July 2014

Intermittent LHRH therapy in the management of castrate-resistant prostate cancer (CRPCa): results of a multi-institutional randomized prospective clinical trial

scientific article published in December 2013

Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer?

scientific article published on 19 March 2013

Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?

scientific article

Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?

scientific article

Is trastuzumab a cost-effective treatment for breast cancer?

scientific article published on 01 October 2008

Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer

scientific article published on 09 November 2006

Simultaneous liver kidney transplantation: a medical decision analysis

scientific article

Societal preferences for distributive justice in the allocation of health care resources: a latent class discrete choice experiment

scientific article published on 21 August 2014

The Cost–Utility of Adjuvant Chemotherapy Using Docetaxel and Cyclophosphamide Compared with Doxorubicin and Cyclophosphamide in Breast Cancer ⬇️

scientific article published on December 1, 2011

The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian Oncology Drug Review 2011-2017.

scientific article published on 20 January 2018

The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada

scientific article published on June 2008

The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty.

scientific article published on April 2007

The cost-utility of sequential adjuvant trastuzumab in women with Her2/Neu-positive breast cancer: an analysis based on updated results from the HERA Trial

scientific article published on 01 July 2009

The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia Seniors' Pharmacare beneficiaries.

scientific article published in June 2004

The politicization of oncology drug funding reviews in Canada

scientific article published on 09 June 2016

Topical corticosteroid prescribing patterns following changes in drug benefit status

scientific article published on June 2003

Use of physician profiles to influence prescribing of topical corticosteroids

scientific article published on 17 June 2005

Utilization of Ambulatory Physician Encounters, Emergency Room Visits, and Hospitalizations by Systemic Lupus Erythematosus Patients: A 13-Year Population Health Study.

scientific article published on 14 December 2015

List of works by Chris D Skedgel

Adherence to guidelines and the screening tool of older persons' potentially inappropriate prescriptions criteria for colchicine dosing for gout treatment in beneficiaries of the Nova Scotia Seniors' Pharmacare Program

Adjuvant chemotherapy for breast cancer: a cost-utility analysis of FEC-D vs. FEC 100.

Adjuvant trastuzumab for breast cancer: uncertainties in clinical and economic evidence following early stopping of the HERA trial

An incremental cost analysis of telehealth in Nova Scotia from a societal perspective

An incremental economic evaluation of targeted and universal influenza vaccination in pregnant women.

Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital

Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial

Considerations and costs of disclosing study findings to research participants

Constant-sum paired comparisons for eliciting stated preferences: a tutorial

Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review.

Cost-effectiveness of interferon beta-1b in slowing multiple sclerosis disability progression. First estimates

Cost-utility analysis of proton pump inhibitors and other gastro-protective agents for prevention of gastrointestinal complications in elderly patients taking nonselective nonsteroidal anti-inflammatory agents

Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole

Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole.

Cost-utility of adjuvant zoledronic acid in patients with breast cancer and low estrogen levels

Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer.

Drug attributes associated with the selection of drugs for reimbursement: a pilot stated preferences experiment with Canadian stakeholders

Effect of copayments on drug use in the presence of annual payment limits.

Gout in the elderly--a population health study

Hospital-based psychiatric service utilization and morbidity in multiple sclerosis

How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?

Identification of patients with systemic lupus erythematosus in administrative healthcare databases

Intermittent LHRH therapy in the management of castrate-resistant prostate cancer (CRPCa): results of a multi-institutional randomized prospective clinical trial

Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer?

Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?

Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?

Is trastuzumab a cost-effective treatment for breast cancer?

Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer

Simultaneous liver kidney transplantation: a medical decision analysis

Societal preferences for distributive justice in the allocation of health care resources: a latent class discrete choice experiment

The Cost–Utility of Adjuvant Chemotherapy Using Docetaxel and Cyclophosphamide Compared with Doxorubicin and Cyclophosphamide in Breast Cancer ⬇️

The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian Oncology Drug Review 2011-2017.

The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada

The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty.

The cost-utility of sequential adjuvant trastuzumab in women with Her2/Neu-positive breast cancer: an analysis based on updated results from the HERA Trial

The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia Seniors' Pharmacare beneficiaries.

The politicization of oncology drug funding reviews in Canada

Topical corticosteroid prescribing patterns following changes in drug benefit status

Use of physician profiles to influence prescribing of topical corticosteroids

Utilization of Ambulatory Physician Encounters, Emergency Room Visits, and Hospitalizations by Systemic Lupus Erythematosus Patients: A 13-Year Population Health Study.